Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM

Condition:   Waldenstrom Macroglobulinemia Intervention:   Drug: Zanubrutinib, Bendamustine and Rituximab Sponsor:   Institute of Hematology & Blood Diseases Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials